Annual Accounts Receivable
$1.50 M
+$210.00 K+16.33%
December 31, 2023
Summary
- As of February 7, 2025, NEPH annual accounts receivable is $1.50 million, with the most recent change of +$210.00 thousand (+16.33%) on December 31, 2023.
- During the last 3 years, NEPH annual accounts receivable has risen by +$132.00 thousand (+9.68%).
- NEPH annual accounts receivable is now -8.84% below its all-time high of $1.64 million, reached on December 31, 2021.
Performance
NEPH Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.69 M
-$187.00 K-9.96%
September 1, 2024
Summary
- As of February 7, 2025, NEPH quarterly accounts receivable is $1.69 million, with the most recent change of -$187.00 thousand (-9.96%) on September 1, 2024.
- Over the past year, NEPH quarterly accounts receivable has increased by +$195.00 thousand (+13.03%).
- NEPH quarterly accounts receivable is now -20.54% below its all-time high of $2.13 million, reached on June 30, 2022.
Performance
NEPH Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NEPH Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.3% | +13.0% |
| 3 y3 years | +9.7% | +13.0% |
| 5 y5 years | +10.1% | +13.0% |
NEPH Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.8% | +16.3% | -20.5% | +31.5% |
| 5 y | 5-year | -8.8% | +43.2% | -20.5% | +94.4% |
| alltime | all time | -8.8% | +1260.0% | -20.5% | >+9999.0% |
Nephros Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.69 M(-10.0%) |
| Jun 2024 | - | $1.88 M(+23.7%) |
| Mar 2024 | - | $1.52 M(+1.5%) |
| Dec 2023 | $1.50 M(+16.3%) | $1.50 M(+3.7%) |
| Sep 2023 | - | $1.44 M(-8.4%) |
| Jun 2023 | - | $1.58 M(-19.7%) |
| Mar 2023 | - | $1.96 M(+52.6%) |
| Dec 2022 | $1.29 M(-21.6%) | $1.29 M(-6.4%) |
| Sep 2022 | - | $1.37 M(-35.4%) |
| Jun 2022 | - | $2.13 M(+64.6%) |
| Mar 2022 | - | $1.29 M(-21.2%) |
| Dec 2021 | $1.64 M(+20.3%) | $1.64 M(+5.5%) |
| Sep 2021 | - | $1.55 M(+12.5%) |
| Jun 2021 | - | $1.38 M(-19.6%) |
| Mar 2021 | - | $1.72 M(+26.0%) |
| Dec 2020 | $1.36 M(+30.5%) | $1.36 M(+51.4%) |
| Sep 2020 | - | $901.00 K(+3.6%) |
| Jun 2020 | - | $870.00 K(-45.5%) |
| Mar 2020 | - | $1.60 M(+52.8%) |
| Dec 2019 | $1.04 M(-23.1%) | $1.04 M(-44.8%) |
| Sep 2019 | - | $1.89 M(+23.1%) |
| Jun 2019 | - | $1.54 M(+23.2%) |
| Mar 2019 | - | $1.25 M(-8.1%) |
| Dec 2018 | $1.36 M(+62.6%) | $1.36 M(-9.9%) |
| Sep 2018 | - | $1.51 M(+76.4%) |
| Jun 2018 | - | $855.00 K(+26.1%) |
| Mar 2018 | - | $678.00 K(-18.9%) |
| Dec 2017 | $836.00 K(+115.5%) | $836.00 K(+11.3%) |
| Sep 2017 | - | $751.00 K(+28.6%) |
| Jun 2017 | - | $584.00 K(+0.3%) |
| Mar 2017 | - | $582.00 K(+50.0%) |
| Dec 2016 | $388.00 K(-2.3%) | $388.00 K(+24.8%) |
| Sep 2016 | - | $311.00 K(-10.1%) |
| Jun 2016 | - | $346.00 K(-39.2%) |
| Mar 2016 | - | $569.00 K(+43.3%) |
| Dec 2015 | $397.00 K(+260.9%) | $397.00 K(+83.8%) |
| Sep 2015 | - | $216.00 K(-26.8%) |
| Jun 2015 | - | $295.00 K(-11.7%) |
| Mar 2015 | - | $334.00 K(+203.6%) |
| Dec 2014 | $110.00 K | $110.00 K(-38.5%) |
| Sep 2014 | - | $179.00 K(+58.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $113.00 K(-76.2%) |
| Mar 2014 | - | $475.00 K(+289.3%) |
| Dec 2013 | $122.00 K(-87.0%) | $122.00 K(+17.3%) |
| Sep 2013 | - | $104.00 K(-70.7%) |
| Jun 2013 | - | $355.00 K(+153.6%) |
| Mar 2013 | - | $140.00 K(-85.0%) |
| Dec 2012 | $935.00 K(-20.1%) | $935.00 K(-12.6%) |
| Sep 2012 | - | $1.07 M(+20.2%) |
| Jun 2012 | - | $890.00 K(-14.4%) |
| Mar 2012 | - | $1.04 M(-11.1%) |
| Dec 2011 | $1.17 M(+258.9%) | $1.17 M(+476.4%) |
| Sep 2011 | - | $203.00 K(-65.4%) |
| Jun 2011 | - | $587.00 K(+2.3%) |
| Mar 2011 | - | $574.00 K(+76.1%) |
| Dec 2010 | $326.00 K(-48.2%) | $326.00 K(-27.4%) |
| Sep 2010 | - | $449.00 K(-31.1%) |
| Jun 2010 | - | $652.00 K(+5.3%) |
| Mar 2010 | - | $619.00 K(-1.6%) |
| Dec 2009 | $629.00 K(+55.7%) | $629.00 K(+19.8%) |
| Sep 2009 | - | $525.00 K(+64.1%) |
| Jun 2009 | - | $320.00 K(-26.6%) |
| Mar 2009 | - | $436.00 K(+7.9%) |
| Dec 2008 | $404.00 K(-3.6%) | $404.00 K(+25.5%) |
| Sep 2008 | - | $322.00 K(+15.8%) |
| Jun 2008 | - | $278.00 K(-31.4%) |
| Mar 2008 | - | $405.00 K(-3.3%) |
| Dec 2007 | $419.00 K(+83.8%) | $419.00 K(+267.5%) |
| Sep 2007 | - | $114.00 K(+1040.0%) |
| Jun 2007 | - | $10.00 K(-96.0%) |
| Mar 2007 | - | $248.00 K(+8.8%) |
| Dec 2006 | $228.00 K(-6.6%) | $228.00 K(-51.8%) |
| Sep 2006 | - | $472.90 K(+26.0%) |
| Jun 2006 | - | $375.30 K(+106.8%) |
| Mar 2006 | - | $181.50 K(-25.6%) |
| Dec 2005 | $244.10 K(+39.6%) | $244.10 K(+6.3%) |
| Sep 2005 | - | $229.60 K(+4.5%) |
| Jun 2005 | - | $219.70 K(-0.7%) |
| Mar 2005 | - | $221.30 K(+26.6%) |
| Dec 2004 | $174.80 K | $174.80 K(+640.7%) |
| Sep 2004 | - | $23.60 K(-2.1%) |
| Jun 2004 | - | $24.10 K |
FAQ
- What is Nephros annual accounts receivable?
- What is the all time high annual accounts receivable for Nephros?
- What is Nephros annual accounts receivable year-on-year change?
- What is Nephros quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Nephros?
- What is Nephros quarterly accounts receivable year-on-year change?
What is Nephros annual accounts receivable?
The current annual accounts receivable of NEPH is $1.50 M
What is the all time high annual accounts receivable for Nephros?
Nephros all-time high annual accounts receivable is $1.64 M
What is Nephros annual accounts receivable year-on-year change?
Over the past year, NEPH annual accounts receivable has changed by +$210.00 K (+16.33%)
What is Nephros quarterly accounts receivable?
The current quarterly accounts receivable of NEPH is $1.69 M
What is the all time high quarterly accounts receivable for Nephros?
Nephros all-time high quarterly accounts receivable is $2.13 M
What is Nephros quarterly accounts receivable year-on-year change?
Over the past year, NEPH quarterly accounts receivable has changed by +$195.00 K (+13.03%)